Home/Filings/4/0000899243-21-017495
4//SEC Filing

Ferguson Joe W. 4

Accession 0000899243-21-017495

CIK 0001630627other

Filed

Apr 28, 8:00 PM ET

Accepted

Apr 29, 9:24 PM ET

Size

10.6 KB

Accession

0000899243-21-017495

Insider Transaction Report

Form 4
Period: 2021-04-27
Ferguson Joe W.
SVP, Research & Development
Transactions
  • Other

    Series A Preferred Stock

    2021-04-27+1,98185,575 total(indirect: By Trust)
    Common Stock (1,981 underlying)
  • Conversion

    Common Stock

    2021-04-27+85,57585,575 total(indirect: By Trust)
  • Conversion

    Series A Preferred Stock

    2021-04-2785,5750 total(indirect: By Trust)
    Common Stock (85,575 underlying)
Holdings
  • Common Stock

    111,115
Footnotes (2)
  • [F1]Each share of the Issuer's Series A Preferred Stock automatically converted into one (1) share of the Issuer's Common Stock immediately upon the closing of the Issuer's initial public offering. The shares had no expiration date.
  • [F2]The Reporting Person received Series A Preferred Stock as a payment-in-kind dividend.

Issuer

TREACE MEDICAL CONCEPTS, INC.

CIK 0001630627

Entity typeother

Related Parties

1
  • filerCIK 0001856496

Filing Metadata

Form type
4
Filed
Apr 28, 8:00 PM ET
Accepted
Apr 29, 9:24 PM ET
Size
10.6 KB